학술논문

Rheumatology Patients’ Experiences of a Mandatory Nationwide Transition to an Adalimumab Biosimilar
Document Type
Article
Source
In: ACR Open Rheumatology. (ACR Open Rheumatology, February 2024, 6(2):64-71)
Subject
Language
English
ISSN
25785745